Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000092

Options or other derivatives

  • President and CEO acquired 105,840 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BLATT LAWRENCE · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +105,840 105,840 D
Loading xslF345X05/form4.xml…